Torrey Pines Law Group's founder, Kevin Buckley, has represented biotechnology innovators for more than 20 years. Prior to becoming a patent attorney, Kevin was a biochemist for many years at UC San Diego as well as in industry on the Torrey Pines mesa. His experience has provided both his clients and his colleagues valuable insight into solving complex legal problems related to securing international biotechnology patents, obtaining regulatory approvals for therapeutic products throughout the world, securing private investment and government funding for biotechnology research and development, in- and out-licensing biotech, biopharmaceutical and diagnostics IP, litigating matters for biotechnology industry clients in federal courts, and even teaching Biotechnology Law at a prominent law school.
Kevin's clients are on the leading edge of biotechnology innovation. Those "biotechnology" innovations (referring to a collection of technologies that use cellular and biomolecular processes to solve problems and make useful products) include technologies that affect our daily lives such as personalized medicine, biosensors, and diagnostics. Kevin has also worked with whole-genome sequencing, "pharming," cloning, regenerative medicine, embryonic stem cell research, and gene editing.
Some of the biotechnology research Kevin has assisted with can even challenge our understanding about the very nature of life. One can imagine, then, that the entire body of "biotechnology law" that affects this patchwork of technologies is as varied and far-reaching as the underlying technologies themselves.
Although some say that biotechnologies were first developed about 10,000 years ago with the domestication of plants and animals, the pace of modern biotechnology development has far exceeded the original pace. Therefore, biotechnology law has become a continuously adaptive body of law that evolves with the pace of biotechnology development. Because biotechnology law is also influenced by business cycles and the market, the most effective way to understand biotechnology law is by studying its evolution at the intersection of law, business, and science. Legal issues at this intersection include intellectual property (especially patents), federal regulation, research funding, approval of products for human use, privacy issues, and international issues, among many other unique legal issues.
The IP attorneys, patent lawyers, engineers, scientists, and patent agents at Torrey Pines Law Group have also worked in a variety of biotechnology industries and have assisted with commercializing, researching, and developing technologies including:
Torrey Pines Law Group, PC serves technology innovators with protecting intellectual property internationally and throughout the U.S., including in major technology hubs such as San Diego, San Francisco, Palo Alto, San Jose, Silicon Valley, Boston, Cambridge, Chicago, Minneapolis, Houston, Dallas, Atlanta, Denver, Seattle, Portland, Boulder, Orlando, the Research Triangle (Raleigh, Durham, and Chapel Hill), the Mid-Atlantic (New Jersey, New York, Philadelphia, Maryland, Virginia, and Washington, DC) and throughout Southern California in Los Angeles, Orange County, Irvine, and La Jolla.
Biotechnology Patent Attorneys - Biopharmaceutical Patent Lawyer - Biotech Law Firm - Therapeutics Regulatory Counsel - Intellectual Property Law Firm